Becton Dickinson - 41 Year Stock Split History | BDX

Stock split history for Becton Dickinson since 1983. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Becton Dickinson Annual Stock Splits
Becton Dickinson Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.358B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.176B 18.25
West Pharmaceutical Services (WST) United States $27.623B 46.70
Cardinal Health (CAH) United States $25.783B 15.50
Align Technology (ALGN) United States $22.677B 45.73
Cooper (COO) United States $17.970B 27.19
Labcorp (LH) United States $16.779B 14.33
Henry Schein (HSIC) United States $8.990B 15.55
DENTSPLY SIRONA (XRAY) United States $6.312B 16.63
Merit Medical Systems (MMSI) United States $4.122B 23.58
STAAR Surgical (STAA) United States $2.285B 71.95
Patterson (PDCO) United States $2.282B 10.93
CONMED (CNMD) United States $2.189B 20.60
Atrion (ATRI) United States $0.679B 34.97
Lifevantage (LFVN) United States $0.086B 13.88
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00